Protalix BioTherapeutics (PLX) Deferred Taxes (2023 - 2026)
Protalix BioTherapeutics (PLX) recorded quarterly Deferred Taxes of $71000.0 in Q1 2026, down 56.44% quarter-over-quarter from $163000.0 in Q4 2025, and up 162.83% on a YoY basis from $27013.5 in Q1 2025.
Protalix BioTherapeutics (PLX) Deferred Taxes (2023 - 2026) Analysis & Trends
Protalix BioTherapeutics' Deferred Taxes history runs 4 years deep, the most recent figure standing at $71000.0 for Q1 2026.
- In Q1 2026, Deferred Taxes rose 162.83% year-over-year to $71000.0; the TTM figure through Mar 2026 stood at $524000.0 (up 100.77% YoY), while the FY2025 annual figure was $340000.0, up 44.07% from the prior year.
- Deferred Taxes was $71000.0 for Q1 2026 at Protalix BioTherapeutics, down from $163000.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $443000.0 in Q3 2024 to a low of -$3.1 million in Q2 2023.
- Historically, Deferred Taxes has averaged -$244500.0 across 4 years, with a median of $48500.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Deferred Taxes surged 1065.79% in 2024, then slumped 86.68% in 2025.
- A 4-year view of Deferred Taxes shows it stood at $38000.0 in 2023, then soared by 1065.79% to $443000.0 in 2024, then tumbled by 63.21% to $163000.0 in 2025, then plunged by 56.44% to $71000.0 in 2026.
- The last three Deferred Taxes figures came in at $71000.0 (Q1 2026), $163000.0 (Q4 2025), and $59000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Protalix BioTherapeutics | 176.47 Mn | 165.67 Mn | 29.62 Mn | 71,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71,000.00 |
| Dec 31, 2025 | 163,000.00 |
| Sep 30, 2025 | 59,000.00 |
| Jun 30, 2025 | 231,000.00 |
| Mar 31, 2025 | -113,000.00 |
| Sep 30, 2024 | 443,000.00 |
| Jun 30, 2024 | -69,000.00 |
| Mar 31, 2024 | -138,000.00 |
| Sep 30, 2023 | 38,000.00 |
| Jun 30, 2023 | -3.13 Mn |